Yasutomo Nakai

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Cerebrospinal Fluid

Liver Metastases

Renal Cell Carcinoma

Top Venues

IJU case reports

Cancer prevention research (Philadelphia, Pa.)

This page only lists publications with an associated author ORCID identifier.

Publications

Harshath Gupta, Hitoshi Inoue, Yasutomo Nakai, Masashi Nakayama, Tracy Jones, Jessica L Hicks, Balasubramanian Kumar, Meltem Gurel, William G Nelson, Angelo M DeMarzo, Srinivasan Yegnasubramanian
Progressive spreading of DNA methylation in the GSTP1 promoter CpG island across transitions from precursors to invasive prostate cancer. Cancer prevention research (Philadelphia, Pa.) (2023)
Yasutomo Nakai, Tomoyuki Otsuka, Takako Inoue, Takatoshi Nawa, Koji Hatano, Yoshiyuki Yamamoto, Akira Nagahara, Masashi Nakayama, Ken-Ichi Kakimoto, Kazuo Nishimura
Two cases of delayed onset of immune-related adverse events after discontinuation of nivolumab in patients with metastatic renal cell cancer. IJU case reports 4 (5) (2021)
Akinaru Yamamoto, Yasutomo Nakai, Toshiki Oka, Tomohiro Kanaki, Yoshiyuki Yamamoto, Akira Nagahara, Masashi Nakayama, Ken-Ichi Kakimoto, Kazuo Nishimura
Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second-line chemotherapy. IJU case reports 3 (6) (2020)
Toshiki Oka, Yoshiyuki Yamamoto, Yohei Okuda, Toshihisa Asakura, Koji Hatano, Yasutomo Nakai, Masashi Nakayama, Ken-Ichi Kakimoto, Fuminobu Sugai, Kazuo Nishimura
Renal cell carcinoma with central nervous system demyelination caused by nivolumab. IJU case reports 4 (1) (2020)